Avanos Medical Inc (FRA:8HH)
€ 21.6 +0.20 (+0.93%) Market Cap: 1.03 Bil Enterprise Value: 1.09 Bil PE Ratio: 0 PB Ratio: 1.49 GF Score: 62/100

Avanos Medical Inc at Morgan Stanley Healthcare Conference Transcript

Sep 09, 2019 / 05:40PM GMT
Release Date Price: €29.61 (-2.63%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Starting here -- there we go, thank you. My name is David Lewis. I'm a medical device analyst here at Morgan Stanley. Thanks for joining us here as we progress into the afternoon. It's my pleasure to have this year a couple of members of management of Avanos, both the CEO Joe Woody as well as Dave Crawford, who is VP, Treasurer and Investor Relations:

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

Joe, you've been up here with me at this conference in the past. So I thought to give you a chance of your thinking through, you taking over this business, and thinking about the last couple of years of transformation. So I'd say, where have you been successful relative to your plans in transforming the businesses and sort of what's been behind?

Joseph F. Woody
Avanos Medical, Inc. - CEO & Director

Right. I mean if I think about our investor conference in New York 2 years ago, clearly only one thing hasn't gone our way and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot